Riskpilot← Back to searchSign inGet full accessKONGSVINGER APOTEK AS
ASActiveOrg 918152652Kristian Walbys Veg 2, 2212 KongsvingerRetail sale of pharmaceutical products · NACE 4773Est. 201611 employees
Revenue 2025
NOK 16,5M
+16% vs 2024
EBITDA margin
2.4%
+73% vs 2024
Equity ratio
-19.4%
Financial strength
Net profit 2025
NOK 252K
+445% vs 2024
| Revenue | NOK 16,5M | +16% |
| EBITDA | NOK 392K | +73% |
| Net profit | NOK 252K | +445% |
| Total assets | NOK 2,1M | -26% |
| Equity | NOK -398K | +39% |
| Employees | 11 | — |
Legal name
KONGSVINGER APOTEK AS
Org number
918152652
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
7. desember 2016
Share capital
NOK 2 901 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Kristian Walbys Veg 2, 2212 Kongsvinger
Phone
+4762829100
Email
kongsvinger.langeland@dittapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9 220 | 9 515 | 10 851 | 14 168 | 16 465 |
| Staff expenses | −1 668 | −2 677 | −2 852 | −3 028 | −3 381 |
| EBITDA | 425 | −741 | −323 | 227 | 392 |
| Depreciation & amort. | −126 | −234 | −200 | −121 | −106 |
| EBIT | 299 | −975 | −523 | 105 | 287 |
| Net financials | −35 | −64 | −60 | −59 | −35 |
| Profit before tax | 264 | −1 039 | −583 | 46 | 252 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 264 | −1 039 | −583 | 46 | 252 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 157 | 2 070 | 2 271 | 2 772 | 2 054 |
| Equity | −75 | −113 | −697 | −650 | −398 |
| Long-term debt | 713 | 483 | 411 | 107 | 0 |
| Short-term debt | 1 519 | 1 700 | 2 557 | 3 315 | 2 452 |
| Total debt | 2 232 | 2 183 | 2 967 | 3 422 | 2 452 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20212025
Equity ratio
-19.4%
This company
38.2%
Market median
-151% vs market
20212025
Return on equity
25189500.0%
This company
18.4%
Market median
+136899357% vs market
20212025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20212025
Asset turnover
8.02×
This company
1.12×
Market median
+616% vs market
20212025
Debt / equity
6.15×
This company
0.62×
Market median
-892% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
MF Chief Executive Officer | Chief Executive Officer | 2018 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Board of Directors | 2016 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2024 | |
| Company | 33.33% | 33.33% | 2024 | |
| Company | 33.33% | 33.33% | 2024 | |
| Company | 14.27% | 14.27% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
KONGSVINGER APOTEK AS Board members of KONGSVINGER APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dina Pauline Engebretsen | Chief Executive Officer | 0 companies |
| Muhammad Fahad Mukhtar | Chief Executive Officer | 0 companies |
| Eivind Vefring | Board of Directors | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |
| Gulzeb Aziz | Board of Directors | 0 companies |